ISSN 1662-4009 (online)

ey0018.12-4 | Type 2 Diabetes | ESPEYB18

12.4. Multisite examination of depression screening scores and correlates among adolescents and young adults with type 2 diabetes

M Monaghan , CA Mara , JC Kichler , SC Westen , A Rawlinson , LM Jacobsen , RN Adams , JY Stone , KK Hood , SA Mulvaney

Can J Diabetes. 2021 Jan 22:S1499–2671(21)00018-6. doi: 10.1016/j.jcjd.2021.01.011. PMID: 33722492.In brief: The presence of depressive symptoms was assessed in 197 adolescents and young adults (ages 12 to 24 years) with T2DM. 19% reported elevated depressive symptoms and 19% admitted thoughts of self-harm. Older age, shorter diabetes duration, higher HbA1c level, being no...

ey0019.10-3 | Clinical Trials | ESPEYB19

10.3. Randomized trial of closed-loop control in very young children with type 1 diabetes

J Ware , JM Allen , CK Boughton , ME Wilinska , S Hartnell , A Thankamony , Beaufort C de , U Schierloh , E Frohlich-Reiterer , JK Mader , TM Kapellen , B Rami-Merhar , M Tauschmann , K Nagl , SE Hofer , FM Campbell , J Yong , KK Hood , J Lawton , S Roze , J Sibayan , J Bocchino , C Kollman , R Hovorka , Consortium KidsAP

N Engl J Med. 2022 Jan 20;386(3):209-219. https://pubmed.ncbi.nlm.nih.gov/35045227/Brief Summary: This multicenter, randomized, crossover trial in 74 very young children (age: 1-7 years) with type 1 diabetes (T1D) tested the safety and efficacy of a hybrid closed-loop system for insulin delivery (CamAPS FX) compared with sensor-augmented pump therapy over 16 weeks. The hybrid closed-loop sy...